Wells Fargo & Company Ligand Pharmaceuticals Inc Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 8,811 shares of LGND stock, worth $923,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,811
Previous 6,850 28.63%
Holding current value
$923,128
Previous $500,000 48.4%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$68.53 - $87.91 $134,387 - $172,391
1,961 Added 28.63%
8,811 $742,000
Q1 2024

May 10, 2024
BUY
$68.64 - $89.2 $80,308 - $104,364
1,170 Added 20.6%
6,850 $500,000
Q4 2023

Feb 09, 2024
BUY
$49.57 - $72.63 $57,947 - $84,904
1,169 Added 25.91%
5,680 $405,000
Q3 2023

Nov 13, 2023
SELL
$58.86 - $72.67 $197,298 - $243,589
-3,352 Reduced 42.63%
4,511 $270,000
Q2 2023

Aug 15, 2023
BUY
$69.53 - $79.33 $258,721 - $295,186
3,721 Added 89.84%
7,863 $566,000
Q1 2023

May 12, 2023
BUY
$65.67 - $77.08 $140,533 - $164,951
2,140 Added 106.89%
4,142 $304,000
Q4 2022

Feb 13, 2023
SELL
$61.72 - $96.74 $40,920 - $64,138
-663 Reduced 24.88%
2,002 $133,000
Q3 2022

Nov 14, 2022
SELL
$0.01 - $107.56 $2 - $25,384
-236 Reduced 8.14%
2,665 $230,000
Q2 2022

Aug 12, 2022
SELL
$74.52 - $117.06 $1.4 Million - $2.2 Million
-18,804 Reduced 86.63%
2,901 $259,000
Q1 2022

May 16, 2022
SELL
$94.99 - $151.56 $1.47 Million - $2.34 Million
-15,465 Reduced 41.61%
21,705 $2.44 Million
Q4 2021

Feb 14, 2022
SELL
$127.69 - $165.85 $874,931 - $1.14 Million
-6,852 Reduced 15.56%
37,170 $5.74 Million
Q3 2021

Nov 15, 2021
BUY
$102.33 - $144.73 $796,127 - $1.13 Million
7,780 Added 21.47%
44,022 $6.13 Million
Q2 2021

Aug 16, 2021
SELL
$113.03 - $155.64 $592,390 - $815,709
-5,241 Reduced 12.63%
36,242 $4.76 Million
Q1 2021

May 13, 2021
BUY
$99.52 - $215.83 $622,398 - $1.35 Million
6,254 Added 17.75%
41,483 $6.32 Million
Q4 2020

Feb 09, 2021
SELL
$80.55 - $106.05 $1.55 Million - $2.04 Million
-19,218 Reduced 35.3%
35,229 $3.5 Million
Q3 2020

Nov 05, 2020
SELL
$89.56 - $126.72 $1.8 Million - $2.55 Million
-20,152 Reduced 27.01%
54,447 $5.19 Million
Q2 2020

Aug 13, 2020
SELL
$68.28 - $123.65 $1.31 Million - $2.37 Million
-19,173 Reduced 20.45%
74,599 $8.34 Million
Q1 2020

May 14, 2020
BUY
$63.37 - $107.88 $5.94 Million - $10.1 Million
93,772 New
93,772 $6.82 Million

Others Institutions Holding LGND

# of Institutions
247
Shares Held
17.5M
Call Options Held
61K
Put Options Held
7.8K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.77B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email